XML 160 R100.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Related party disclosures (Details)
€ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 22, 2024
shares
Dec. 12, 2022
shares
Oct. 18, 2021
shares
Mar. 10, 2021
shares
Aug. 31, 2023
EUR (€)
May 31, 2022
EUR (€)
Mar. 31, 2023
EUR (€)
Dec. 31, 2023
EUR (€)
shares
Dec. 31, 2022
EUR (€)
shares
Dec. 31, 2021
EUR (€)
shares
Dec. 31, 2021
$ / shares
shares
Dec. 31, 2019
loan
Sep. 30, 2021
EUR (€)
Related party disclosures                          
Consulting fees               € 212 € 518        
Amount paid                   € 25,000      
Common shares                          
Related party disclosures                          
Price per share | $ / shares                     $ 16    
Prior VSOP                          
Related party disclosures                          
Number of shares received | shares 786,746 777,260 765,223 759,677       0 777,260        
Dietmar Hopp                          
Related party disclosures                          
Number of convertible loans | loan                       2  
Dietmar Hopp | Common shares                          
Related party disclosures                          
Number of shares issued | shares                   100,000,000 100,000,000    
Dievini Hopp BioTech holding GmbH & Co. KG                          
Related party disclosures                          
Reimbursement of travel cost               € 1 € 58        
Clarentis SRL                          
Related party disclosures                          
Contractual obligation amount                         € 100
Expense recognized from related party transaction               107          
BePharBel Manufacturing S.A                          
Related party disclosures                          
Settlement amount           € 3,900              
Amount paid                   € 4,016      
Franz-Werner Haas                          
Related party disclosures                          
Expense recognized from related party transaction               65          
Payment compensated               40          
Alexander Zehnder                          
Related party disclosures                          
Expenses to handle future service agreement             € 51            
Barker BioMedical GmbH                          
Related party disclosures                          
Expense recognized from related party transaction               14          
Craig Tooman                          
Related party disclosures                          
Expense recognized from related party transaction               € 5          
Rittershaus Rechtsanwaelte                          
Related party disclosures                          
Notice period for termination at the option               3 months          
Consulting fees                   € 757      
Service rendered issue               € 16          
Mariola Fotin-Mleczek                          
Related party disclosures                          
Consulting fees               2 20        
Income tax and social security liability receivable                 131        
Florian von der Mlbe                          
Related party disclosures                          
Income tax and social security liability receivable                 559        
Dr. Ingmar Hrr                          
Related party disclosures                          
Income tax and social security liability receivable                 573        
Immatics Biotechnologies GmbH                          
Related party disclosures                          
Equity interest held         16.70%                
Purchases of related party         € 178                
CureVac Printer GmbH                          
Related party disclosures                          
Consulting fees               146          
Grid Europe                          
Related party disclosures                          
Expense recognized from related party transaction               23          
Baron Jean Stephenne                          
Related party disclosures                          
Equity interest held                   15.61%      
Vincent Stephenne                          
Related party disclosures                          
Equity interest held                   1.43%      
Antony Blanc | Clarentis SRL                          
Related party disclosures                          
Consulting fees               € 85 € 69 € 0